- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
According to our latest study, the global Intravitreal Injectable market size was valued at USD 14950 million in 2022 and is forecast to a readjusted size of USD 23690 million by 2029 with a CAGR of 6.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
This report is a detailed and comprehensive analysis for global Intravitreal Injectable market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Drug and by Disease. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intravitreal Injectable market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intravitreal Injectable market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intravitreal Injectable market size and forecasts, by Drug and by Disease, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intravitreal Injectable market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intravitreal Injectable
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intravitreal Injectable market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech and Kanghong Pharmaceutical. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intravitreal Injectable market is split by Drug and by Disease. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Drug, and by Disease in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug
Anti-VEGF
Steroids
Others
Market segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Major players covered
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravitreal Injectable product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravitreal Injectable, with price, sales, revenue and global market share of Intravitreal Injectable from 2018 to 2023.
Chapter 3, the Intravitreal Injectable competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Drug and disease, with sales market share and growth rate by drug, disease, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravitreal Injectable market forecast, by regions, drug and disease, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravitreal Injectable.
Chapter 14 and 15, to describe Intravitreal Injectable sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Intravitreal Injectable
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Drug
1.3.1 Overview: Global Intravitreal Injectable Consumption Value by Drug: 2018 Versus 2022 Versus 2029
1.3.2 Anti-VEGF
1.3.3 Steroids
1.3.4 Others
1.4 Market Analysis by Disease
1.4.1 Overview: Global Intravitreal Injectable Consumption Value by Disease: 2018 Versus 2022 Versus 2029
1.4.2 Macular Degeneration
1.4.3 Macular Edema
1.4.4 Uveitis
1.4.5 Retinal Vein Occlusion
1.4.6 Others
1.5 Global Intravitreal Injectable Market Size & Forecast
1.5.1 Global Intravitreal Injectable Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intravitreal Injectable Sales Quantity (2018-2029)
1.5.3 Global Intravitreal Injectable Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Regeneron Pharmaceuticals (Eylea)
2.1.1 Regeneron Pharmaceuticals (Eylea) Details
2.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
2.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
2.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Intravitreal Injectable Product and Services
2.2.4 Allergan Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Allergan Recent Developments/Updates
2.3 EyePoint Pharmaceuticals
2.3.1 EyePoint Pharmaceuticals Details
2.3.2 EyePoint Pharmaceuticals Major Business
2.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
2.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Intravitreal Injectable Product and Services
2.4.4 Genentech Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Genentech Recent Developments/Updates
2.5 Kanghong Pharmaceutical
2.5.1 Kanghong Pharmaceutical Details
2.5.2 Kanghong Pharmaceutical Major Business
2.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Services
2.5.4 Kanghong Pharmaceutical Intravitreal Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kanghong Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Intravitreal Injectable by Manufacturer
3.1 Global Intravitreal Injectable Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intravitreal Injectable Revenue by Manufacturer (2018-2023)
3.3 Global Intravitreal Injectable Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intravitreal Injectable by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intravitreal Injectable Manufacturer Market Share in 2022
3.4.2 Top 6 Intravitreal Injectable Manufacturer Market Share in 2022
3.5 Intravitreal Injectable Market: Overall Company Footprint Analysis
3.5.1 Intravitreal Injectable Market: Region Footprint
3.5.2 Intravitreal Injectable Market: Company Product Type Footprint
3.5.3 Intravitreal Injectable Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intravitreal Injectable Market Size by Region
4.1.1 Global Intravitreal Injectable Sales Quantity by Region (2018-2029)
4.1.2 Global Intravitreal Injectable Consumption Value by Region (2018-2029)
4.1.3 Global Intravitreal Injectable Average Price by Region (2018-2029)
4.2 North America Intravitreal Injectable Consumption Value (2018-2029)
4.3 Europe Intravitreal Injectable Consumption Value (2018-2029)
4.4 Asia-Pacific Intravitreal Injectable Consumption Value (2018-2029)
4.5 South America Intravitreal Injectable Consumption Value (2018-2029)
4.6 Middle East and Africa Intravitreal Injectable Consumption Value (2018-2029)
5 Market Segment by Drug
5.1 Global Intravitreal Injectable Sales Quantity by Drug (2018-2029)
5.2 Global Intravitreal Injectable Consumption Value by Drug (2018-2029)
5.3 Global Intravitreal Injectable Average Price by Drug (2018-2029)
6 Market Segment by Disease
6.1 Global Intravitreal Injectable Sales Quantity by Disease (2018-2029)
6.2 Global Intravitreal Injectable Consumption Value by Disease (2018-2029)
6.3 Global Intravitreal Injectable Average Price by Disease (2018-2029)
7 North America
7.1 North America Intravitreal Injectable Sales Quantity by Drug (2018-2029)
7.2 North America Intravitreal Injectable Sales Quantity by Disease (2018-2029)
7.3 North America Intravitreal Injectable Market Size by Country
7.3.1 North America Intravitreal Injectable Sales Quantity by Country (2018-2029)
7.3.2 North America Intravitreal Injectable Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intravitreal Injectable Sales Quantity by Drug (2018-2029)
8.2 Europe Intravitreal Injectable Sales Quantity by Disease (2018-2029)
8.3 Europe Intravitreal Injectable Market Size by Country
8.3.1 Europe Intravitreal Injectable Sales Quantity by Country (2018-2029)
8.3.2 Europe Intravitreal Injectable Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intravitreal Injectable Sales Quantity by Drug (2018-2029)
9.2 Asia-Pacific Intravitreal Injectable Sales Quantity by Disease (2018-2029)
9.3 Asia-Pacific Intravitreal Injectable Market Size by Region
9.3.1 Asia-Pacific Intravitreal Injectable Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intravitreal Injectable Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intravitreal Injectable Sales Quantity by Drug (2018-2029)
10.2 South America Intravitreal Injectable Sales Quantity by Disease (2018-2029)
10.3 South America Intravitreal Injectable Market Size by Country
10.3.1 South America Intravitreal Injectable Sales Quantity by Country (2018-2029)
10.3.2 South America Intravitreal Injectable Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intravitreal Injectable Sales Quantity by Drug (2018-2029)
11.2 Middle East & Africa Intravitreal Injectable Sales Quantity by Disease (2018-2029)
11.3 Middle East & Africa Intravitreal Injectable Market Size by Country
11.3.1 Middle East & Africa Intravitreal Injectable Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intravitreal Injectable Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intravitreal Injectable Market Drivers
12.2 Intravitreal Injectable Market Restraints
12.3 Intravitreal Injectable Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intravitreal Injectable and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravitreal Injectable
13.3 Intravitreal Injectable Production Process
13.4 Intravitreal Injectable Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravitreal Injectable Typical Distributors
14.3 Intravitreal Injectable Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Intravitreal Injectable Consumption Value by Drug, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intravitreal Injectable Consumption Value by Disease, (USD Million), 2018 & 2022 & 2029
Table 3. Regeneron Pharmaceuticals (Eylea) Basic Information, Manufacturing Base and Competitors
Table 4. Regeneron Pharmaceuticals (Eylea) Major Business
Table 5. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
Table 6. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
Table 8. Allergan Basic Information, Manufacturing Base and Competitors
Table 9. Allergan Major Business
Table 10. Allergan Intravitreal Injectable Product and Services
Table 11. Allergan Intravitreal Injectable Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Allergan Recent Developments/Updates
Table 13. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. EyePoint Pharmaceuticals Major Business
Table 15. EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
Table 16. EyePoint Pharmaceuticals Intravitreal Injectable Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. EyePoint Pharmaceuticals Recent Developments/Updates
Table 18. Genentech Basic Information, Manufacturing Base and Competitors
Table 19. Genentech Major Business
Table 20. Genentech Intravitreal Injectable Product and Services
Table 21. Genentech Intravitreal Injectable Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Genentech Recent Developments/Updates
Table 23. Kanghong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Kanghong Pharmaceutical Major Business
Table 25. Kanghong Pharmaceutical Intravitreal Injectable Product and Services
Table 26. Kanghong Pharmaceutical Intravitreal Injectable Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Kanghong Pharmaceutical Recent Developments/Updates
Table 28. Global Intravitreal Injectable Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global Intravitreal Injectable Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Intravitreal Injectable Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in Intravitreal Injectable, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Intravitreal Injectable Production Site of Key Manufacturer
Table 33. Intravitreal Injectable Market: Company Product Type Footprint
Table 34. Intravitreal Injectable Market: Company Product Application Footprint
Table 35. Intravitreal Injectable New Market Entrants and Barriers to Market Entry
Table 36. Intravitreal Injectable Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Intravitreal Injectable Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global Intravitreal Injectable Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global Intravitreal Injectable Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Intravitreal Injectable Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Intravitreal Injectable Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global Intravitreal Injectable Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global Intravitreal Injectable Sales Quantity by Drug (2018-2023) & (K Units)
Table 44. Global Intravitreal Injectable Sales Quantity by Drug (2024-2029) & (K Units)
Table 45. Global Intravitreal Injectable Consumption Value by Drug (2018-2023) & (USD Million)
Table 46. Global Intravitreal Injectable Consumption Value by Drug (2024-2029) & (USD Million)
Table 47. Global Intravitreal Injectable Average Price by Drug (2018-2023) & (US$/Unit)
Table 48. Global Intravitreal Injectable Average Price by Drug (2024-2029) & (US$/Unit)
Table 49. Global Intravitreal Injectable Sales Quantity by Disease (2018-2023) & (K Units)
Table 50. Global Intravitreal Injectable Sales Quantity by Disease (2024-2029) & (K Units)
Table 51. Global Intravitreal Injectable Consumption Value by Disease (2018-2023) & (USD Million)
Table 52. Global Intravitreal Injectable Consumption Value by Disease (2024-2029) & (USD Million)
Table 53. Global Intravitreal Injectable Average Price by Disease (2018-2023) & (US$/Unit)
Table 54. Global Intravitreal Injectable Average Price by Disease (2024-2029) & (US$/Unit)
Table 55. North America Intravitreal Injectable Sales Quantity by Drug (2018-2023) & (K Units)
Table 56. North America Intravitreal Injectable Sales Quantity by Drug (2024-2029) & (K Units)
Table 57. North America Intravitreal Injectable Sales Quantity by Disease (2018-2023) & (K Units)
Table 58. North America Intravitreal Injectable Sales Quantity by Disease (2024-2029) & (K Units)
Table 59. North America Intravitreal Injectable Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America Intravitreal Injectable Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America Intravitreal Injectable Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Intravitreal Injectable Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Intravitreal Injectable Sales Quantity by Drug (2018-2023) & (K Units)
Table 64. Europe Intravitreal Injectable Sales Quantity by Drug (2024-2029) & (K Units)
Table 65. Europe Intravitreal Injectable Sales Quantity by Disease (2018-2023) & (K Units)
Table 66. Europe Intravitreal Injectable Sales Quantity by Disease (2024-2029) & (K Units)
Table 67. Europe Intravitreal Injectable Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe Intravitreal Injectable Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe Intravitreal Injectable Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Intravitreal Injectable Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Intravitreal Injectable Sales Quantity by Drug (2018-2023) & (K Units)
Table 72. Asia-Pacific Intravitreal Injectable Sales Quantity by Drug (2024-2029) & (K Units)
Table 73. Asia-Pacific Intravitreal Injectable Sales Quantity by Disease (2018-2023) & (K Units)
Table 74. Asia-Pacific Intravitreal Injectable Sales Quantity by Disease (2024-2029) & (K Units)
Table 75. Asia-Pacific Intravitreal Injectable Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific Intravitreal Injectable Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific Intravitreal Injectable Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Intravitreal Injectable Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Intravitreal Injectable Sales Quantity by Drug (2018-2023) & (K Units)
Table 80. South America Intravitreal Injectable Sales Quantity by Drug (2024-2029) & (K Units)
Table 81. South America Intravitreal Injectable Sales Quantity by Disease (2018-2023) & (K Units)
Table 82. South America Intravitreal Injectable Sales Quantity by Disease (2024-2029) & (K Units)
Table 83. South America Intravitreal Injectable Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America Intravitreal Injectable Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America Intravitreal Injectable Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Intravitreal Injectable Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Intravitreal Injectable Sales Quantity by Drug (2018-2023) & (K Units)
Table 88. Middle East & Africa Intravitreal Injectable Sales Quantity by Drug (2024-2029) & (K Units)
Table 89. Middle East & Africa Intravitreal Injectable Sales Quantity by Disease (2018-2023) & (K Units)
Table 90. Middle East & Africa Intravitreal Injectable Sales Quantity by Disease (2024-2029) & (K Units)
Table 91. Middle East & Africa Intravitreal Injectable Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa Intravitreal Injectable Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa Intravitreal Injectable Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Intravitreal Injectable Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Intravitreal Injectable Raw Material
Table 96. Key Manufacturers of Intravitreal Injectable Raw Materials
Table 97. Intravitreal Injectable Typical Distributors
Table 98. Intravitreal Injectable Typical Customers
List of Figures
Figure 1. Intravitreal Injectable Picture
Figure 2. Global Intravitreal Injectable Consumption Value by Drug, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intravitreal Injectable Consumption Value Market Share by Drug in 2022
Figure 4. Anti-VEGF Examples
Figure 5. Steroids Examples
Figure 6. Others Examples
Figure 7. Global Intravitreal Injectable Consumption Value by Disease, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Intravitreal Injectable Consumption Value Market Share by Disease in 2022
Figure 9. Macular Degeneration Examples
Figure 10. Macular Edema Examples
Figure 11. Uveitis Examples
Figure 12. Retinal Vein Occlusion Examples
Figure 13. Others Examples
Figure 14. Global Intravitreal Injectable Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Intravitreal Injectable Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Intravitreal Injectable Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Intravitreal Injectable Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Intravitreal Injectable Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Intravitreal Injectable Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Intravitreal Injectable by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Intravitreal Injectable Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Intravitreal Injectable Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Intravitreal Injectable Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Intravitreal Injectable Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Intravitreal Injectable Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Intravitreal Injectable Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Intravitreal Injectable Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Intravitreal Injectable Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Intravitreal Injectable Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Intravitreal Injectable Sales Quantity Market Share by Drug (2018-2029)
Figure 31. Global Intravitreal Injectable Consumption Value Market Share by Drug (2018-2029)
Figure 32. Global Intravitreal Injectable Average Price by Drug (2018-2029) & (US$/Unit)
Figure 33. Global Intravitreal Injectable Sales Quantity Market Share by Disease (2018-2029)
Figure 34. Global Intravitreal Injectable Consumption Value Market Share by Disease (2018-2029)
Figure 35. Global Intravitreal Injectable Average Price by Disease (2018-2029) & (US$/Unit)
Figure 36. North America Intravitreal Injectable Sales Quantity Market Share by Drug (2018-2029)
Figure 37. North America Intravitreal Injectable Sales Quantity Market Share by Disease (2018-2029)
Figure 38. North America Intravitreal Injectable Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Intravitreal Injectable Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Intravitreal Injectable Sales Quantity Market Share by Drug (2018-2029)
Figure 44. Europe Intravitreal Injectable Sales Quantity Market Share by Disease (2018-2029)
Figure 45. Europe Intravitreal Injectable Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Intravitreal Injectable Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Intravitreal Injectable Sales Quantity Market Share by Drug (2018-2029)
Figure 53. Asia-Pacific Intravitreal Injectable Sales Quantity Market Share by Disease (2018-2029)
Figure 54. Asia-Pacific Intravitreal Injectable Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Intravitreal Injectable Consumption Value Market Share by Region (2018-2029)
Figure 56. China Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Intravitreal Injectable Sales Quantity Market Share by Drug (2018-2029)
Figure 63. South America Intravitreal Injectable Sales Quantity Market Share by Disease (2018-2029)
Figure 64. South America Intravitreal Injectable Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Intravitreal Injectable Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Intravitreal Injectable Sales Quantity Market Share by Drug (2018-2029)
Figure 69. Middle East & Africa Intravitreal Injectable Sales Quantity Market Share by Disease (2018-2029)
Figure 70. Middle East & Africa Intravitreal Injectable Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Intravitreal Injectable Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Intravitreal Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Intravitreal Injectable Market Drivers
Figure 77. Intravitreal Injectable Market Restraints
Figure 78. Intravitreal Injectable Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Intravitreal Injectable in 2022
Figure 81. Manufacturing Process Analysis of Intravitreal Injectable
Figure 82. Intravitreal Injectable Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
